2025 noticed some large names, like Circle, go public to rousing success. On the M&A aspect, blockbuster offers like Google’s $32 billion Wiz acquisition made headlines.
However the hoped-for rising tide of exits didn’t come to elevate all boats. Some IPOs, like Navan, met with extra muted reception. And general IPO exercise, whereas up from current lows, stays under historic ranges.
As 2026 will get underway, the basic circumstances that affect non-public market exits are largely the identical: Non-public firms are larger than ever by valuation, however additionally they have extra liquidity levers than ever to tug without having to faucet the general public markets. However that privilege is reserved for the easiest of breed.
Additional down the non-public firm meals chain, issues are extra sophisticated. Even for some promising AI startups, an acquihire to a large is proving way more interesting than going at it alone. Which implies acquisitions and different artistic variations of dealmaking are additionally very a lot in play.
Right here’s how Time period Sheet readers are trying on the exit panorama in 2026, and what they’re predicting for IPOs and M&A.
Notice: Solutions have been edited for readability and brevity.
IPOs
IPO momentum will lengthen into early 2026, then sluggish. Proper now, public equities are exceptionally sturdy, with excessive investor receptivity to tech, strong liquidity, and powerful quantity. There’s a four-year backlog of tech firms able to go public, and this pent-up demand will proceed releasing by way of Q1 or Q2 2026. However the window received’t keep open indefinitely. —Isabelle Freidheim, founder and managing accomplice, Athena Capital
The IPO market will proceed to construct on the successes of 2025. Our current buyside discussions make it clear that the institutional market will probably be selective however look to place extra capital to work behind their greatest concepts and develop with their winners. —Seth Rubin, Stifel head of worldwide fairness capital markets
Though the U.S./U.Ok. IPO markets are exhibiting early indicators of reawakening, optimism will stay measured. The opening of the IPO market will probably be a really vital occasion. The backlog is giant and a constructive set off is required to jumpstart the method of firms going public. —Ivan Nikkhoo, managing accomplice, Navigate Ventures
The IPO market will see extra high-end, big-name firms go public as valuations enhance, whereas smaller issuers will proceed to battle till significant reforms make the method extra environment friendly and cost-effective. —Brad Bernstein, managing accomplice, FTV Capital
We count on 2026 to convey strong crypto-asset dealmaking usually, together with M&A exercise within the prediction markets and IPOs, in addition to public tokenization transactions if we obtain some useful aid from the SEC on them. —Ben Cohen, accomplice, Latham & Watkins
With a uneven IPO window, [in life sciences] later-stage firms are staying non-public longer and infrequently operating dual-track M&A/go-public processes. Count on sustained excessive ranges of exercise in biotech and oncology sectors, each in earlier and later stage property. —Mike Patrone, know-how, life sciences, and personal fairness accomplice, Goodwin
Mergers and acquisitions
A $50B+ AI software program acquisition reshapes the market. As a pleasant regulatory atmosphere continues and the financing capability of incumbents grows—particularly in the event that they pull again from hyperscaler spending and release tens of billions of {dollars}—I predict we’ll see a $50B+ AI software program acquisition. —Jai Das, cofounder, president and accomplice, Sapphire Ventures
The deal atmosphere will probably be extra lively, however bigger buyout offers will doubtless be episodic and extremely aggressive.—Luke Sarsfield, CEO, P10
In 2026, fintech will enter a section outlined by consolidation. The businesses that obtain actual product–market match, sturdy unit economics, and defensible information benefits will pull decisively forward, both by buying smaller gamers. —Ben Borodach, cofounder and CEO, April
I believe we’ll see plenty of AI funding to assist loss-related actions (FNOL, fraud detection, and many others.). We’ll additionally proceed to see non-public fairness go after insurance coverage distribution as a goal sector whereas carriers preserve snapping up ingenious/artistic new underwriters. —David Seider, CCO, TheZebra.com
2026 will mark the 12 months of biotech coming again in vogue. Large pharma, with over $1 trillion in money, will make vital acquisitions of venture-backed biotech firms targeted on best-in-class therapies in oncology and metabolic illnesses. —Steven Yang, head of worldwide enterprise investments, Schroders
Cross border M&A as a proportion of worldwide deal volumes is close to a five-year excessive regardless of the commerce wars and deglobalization headlines. Japan, which is present process an financial revitalization, will proceed to shine beneath its new prime minister, Sanae Takaichi, company governance reforms and rising curiosity from corporates and sponsors alike. —Michal Katz, head of funding and company banking, Mizuho Americas
M&A exercise will stay strong, however the exit atmosphere for the excessive a number of investments made in 2019 and 2021 will nonetheless be tough. —Eric Zinterhofer, founding accomplice, Searchlight Capital Companions
Enterprise capital-backed startups will begin to merge, making unlikely companions of corporations who sometimes compete for offers. This development, which began with a trickle in 2025, will speed up as startups search for methods to maintain progress and obtain scale for a possible public itemizing or PE exit —Arvind Purushotham, head of Citi Ventures
Secondaries, tenders, and extra
A defining development for 2026 would be the rise of secondary markets in non-public investing. As startups stay non-public longer and conventional IPOs grow to be much less frequent, traders are more and more looking for liquidity options by way of GP-led continuation automobiles, structured secondaries, and different private-market mechanisms. —Kal Amin, managing accomplice, 1848 Ventures
Regardless of our perception that liquidity will return to personal fairness in 2026, we see the secondary market reaching a brand new transaction quantity excessive in 2026 after the file quantity seen in 2025. Why? As a result of we consider that as distributions are available so will capital calls, leaving many LPs nonetheless overallocated to personal fairness for a interval to come back. And that LPs will probably be extra lively in how they handle their non-public fairness portfolios in good instances and dangerous. Thus, we predict the secondary market will attain $250B in quantity in 2026. —Yann Robard, managing accomplice, Dawson Companions
The secondary markets will get noisy. The continued IPO drought will collide with the growth in registered options, additional accelerating the growth of the secondary market—institutional capital remains to be on the wheel as new retail capital steps on the gasoline. Prepare to match notes on non-public firm valuations on the neighborhood block occasion as premiums rise, positions change palms extra quickly, and a “hot potato” atmosphere introduces new structural danger. —Larry Aschebrook, founder and managing accomplice, G Squared
With the financial system rising at a considerably surprisingly stable tempo and inflation remaining elevated, the Fed has little motive – not to mention urgency – to additional lower charges. Which means coverage is unlikely to loosen a lot within the close to time period, preserving charges increased than many anticipated and presumably disappointing traders, until inflation drops sharply or the job weakens unexpectedly. —Dr. Lindsey Piegza, Stifel chief economist
See you tomorrow,
VENTURE CAPITAL
– DayOne Information Facilities, a Singapore-based information middle platform, entered into definitive agreements for $2 billion in Sequence C funding, led by Coatue and joined by others.
– interos.ai, an Arlington, Va.-based developer of provide chain danger administration software program, raised $20 million in funding from Blue Owl Capital and Structural Capital.
– Uncommon, a San Francisco-based platform designed to alter how AI talks about manufacturers and merchandise, raised $3.6 million in funding from BoxGroup, Lengthy Journey Ventures, Y Combinator, and others.
PRIVATE EQUITY
– Align Capital Companions acquired Armko Industries, a Dallas-Fort Value, Texas-based constructing envelope, roofing, and waterproofing consulting companies. Monetary phrases weren’t disclosed.
– J.C. Flowers acquired Elephant Insurance coverage, a Richmond, Va.-based automobile insurance coverage firm. Monetary phrases weren’t disclosed.
– Oakley Capital acquired a majority stake in GLAS, a London, U.Ok.-based supplier of mortgage administration and bond trustee companies. La Caisse can also be buying a minority stake. Monetary phrases weren’t disclosed.
– Wingman Progress Companions acquired a majority stake in InterProse, a Vancouver, Wash.-based developer of debt assortment software program. Monetary phrases weren’t disclosed.
EXITS
– Bridgepoint agreed to accumulate Interpath, a London, U.Ok.-based restructuring and monetary advisory agency, from H.I.G. Capital. Monetary phrases weren’t disclosed.
– Frontline Highway Security, a portfolio firm of Bain Capital, acquired Floor Preparation Applied sciences, a New Kingstown, Pa.-based highway security firm, from Dominus Capital. Monetary phrases weren’t disclosed.
– TPG acquired a majority stake in Trustwell, a Beaverton, Ore.-based developer of regulatory, compliance, and traceability software program for the meals business, from The Riverside Firm. Monetary phrases weren’t disclosed.
OTHERS
– Coinbase agreed to accumulate The Clearing Firm, a San Francisco-based prediction markets firm. Monetary phrases weren’t disclosed.
– dormakaba agreed to accumulate Avant-Garde Techniques, a Clarksville, Ind.-based turnstile management firm. Monetary phrases weren’t disclosed.
IPOS
– Aktis Oncology, a Boston, Mass.-based biotech firm targeted on stable tumors, plans to boost as much as $212.4 million in an providing of 11.8 million shares priced between $16 and $18 on the Nasdaq. The corporate posted $6 million in income for the 12 months ended Sept. 30. MPM BioImpact, Vida Ventures, EcoR1 Capital, and Blue Owl Capital Holdings again the corporate.
FUNDS + FUNDS OF FUNDS
– Antler, a Singapore-based enterprise capital agency, raised $160 million for its second fund targeted on early-stage firms in AI and different sectors.
PEOPLE
– Menlo Ventures, a Menlo Park, Calif.-based enterprise capital agency, promoted Deborah Carrillo to accomplice.
– Spectrum Fairness, a Boston, Mass., San Francisco, and London, U.Ok.-based progress fairness agency, promoted Michael Radonich and Matt Neidlinger to managing director.
